"BMI View: We continue to hold our subdued outlook for the Lithuanian pharmaceuticals market duringthe next few years, on account of the changing economic and demographic situation. We expect limitedlow single digit growth in 2012, with the market expected to increase by a local currency margin of 2.5%year-on-year (y-o-y) to reach LTL1.68bn (US$618mn) in 2012 at consumer prices. However, in US dollarterms, the market's value will shrink by 6.3%, indicating the challenges facing companies operating in themarket.Headline Expenditure Projections?? Pharmaceuticals: LTL1.64bn (US$659mn) in 2011 to LTL1.68bn (US$618mn) in 2012; +2.5%in local curre...
No comments:
Post a Comment